Nomograms for prostate cancer - Is their use evidence-based?

Nature Clinical Practice Urology

Volumn 2, Issue 10, 2005, Pages 462-463

  Stapleton, Alan M F ^a   Pinnock, Carole B ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ALGORITHM; BEAM THERAPY; BRACHYTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CORRELATION ANALYSIS; DECISION MAKING; EVIDENCE BASED MEDICINE; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MATHEMATICAL MODEL; NOMOGRAM; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; STATISTICAL MODEL; TREATMENT OUTCOME; TUMOR VOLUME;

EVIDENCE-BASED MEDICINE; HUMANS; MALE; NOMOGRAMS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 27744608901     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0300     Document Type: Review

References (10)

1. Partin AW et al. (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277: 1445-1451
2. Cagiannos I et al. (2003) A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170: 1798-1803
3. Stamey TA et al. (2004) The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? J Urol 172: 1297-1301
4. Winkler MH et al. (2004) Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: A multicentre audit. BJU Int 93: 725-729
5. Greene KL et al. (2004) Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: Results from Cancer of the Prostate Strategic Urological Research Endeavor (CAPSURE). J Urol 171: 2255-2259
6. San Francisco IF et al. (2004) Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen. J Urol 171: 1492-1499
7. Stapleton A et al. (2005) Patient profile predicts findings from radical prostatectomy series. BJU Int 95 (Suppl 1): 16
8. Kattan MW and Scardino PT (2002) Prediction of progression: Nomograms of clinical utility. Clin Prostate Cancer 1: 90-96
9. Di Blasio CJ et al. (2003) Predicting clinical end points: Treatment nomograms in prostate cancer. Semin Oncol 30: 567-586
10. Steginga SK et al. (2002) Making decisions about treatment for localized prostate cancer. BJU Int 89: 255-260